Rigel Pharmaceuticals
RIGL
RIGL
138 hedge funds and large institutions have $150M invested in Rigel Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 44 increasing their positions, 35 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.69% less ownership
Funds ownership: 8.09% → 7.4% (-0.69%)
4% less capital invested
Capital invested by funds: $157M → $150M (-$6.88M)
Holders
138
Holding in Top 10
–
Calls
$579K
Puts
$165K
Top Buyers
| 1 | +$7.76M | |
| 2 | +$4.11M | |
| 3 | +$4.07M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$3.49M |
| 5 |
Two Sigma Advisers
New York
|
+$1.93M |
Top Sellers
| 1 | -$23.7M | |
| 2 | -$10.2M | |
| 3 | -$1.8M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$1.61M |
| 5 |
Morgan Stanley
New York
|
-$1.52M |